Interstitial lung disease and myositis-specific and associated autoantibodies: Clinical manifestations, survival and the performance of the new ATS/ERS criteria for interstitial pneumonia with autoimmune features (IPAF)

详细信息    查看全文

• 作者：Mayra Mej&iacute ; a^a ; Denisse Herrera-Bringas^a ; Diana I. Pé ; rez-Romá ; n^c ; Hermes Rivero^c ; Heidegger Mateos-Toledo^a ; Pedro Castorena-Garc&iacute ; a^a ; José ; E. Figueroa^d ; Jorge Rojas-Serrano^b ; ^{jrojas@iner.gob.mx}
• 刊名：Respiratory Medicine
• 出版年：2017
• 出版时间：February 2017
• 年：2017
• 卷：123
• 期：Complete
• 页码：79-86
• 全文大小：437 K
• 卷排序：123

文摘

Patients differ in clinical manifestations according to the autoantibody profile. Only 50% of the patients fulfilled BPC. However, those patients that did not fulfill BPC, were classified as IPAF. There was no difference in survival among BPC and IPAF patients. Jo-1 patients had a better survival and mortality was associated to the extent of lung inflammation.